CHONLUTEN

This tripeptide belongs to the Khavinson bioregulator family, a class of short peptides developed by Russian scientist Vladimir Khavinson for tissue-specific regeneration. Researchers investigate it primarily for its potential effects on respiratory tract function and the health of mucosal surfaces in the lungs. Most studies focus on age-related decline in respiratory tissue integrity.

The peptide appears to work by binding to specific DNA sequences in lung epithelial cells, potentially influencing the expression of genes involved in tissue repair and cellular maintenance. Think of it as a molecular signal that tells respiratory cells how to maintain themselves properly. This regulatory approach differs from direct pharmacological intervention, instead working through the cell's own genetic machinery.